Pharmaceutical industry: "The Agnelli and Peugeot families are counting on Mérieux to move away from the axles"
Exor, the investment vehicle of Agnelli, announced on Thursday that it had doubled its stake in BioMérieux. Is investing in health to immunize itself from the travails of the automobile sector the new strategy of groups in the sector, wonders Isabelle Chaperon, a columnist in the Economics section of Le Monde.
We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.